Kolexia
Ugo Valerie
Hématologie
Hôpital Larrey Angers
Angers, France
93 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Thrombocytémie essentielle Syndromes myéloprolifératifs Thrombocytose Polyglobulie Myélofibrose primitive Polyglobulie primitive essentielle Leucémies Leucémie aigüe myéloïde Thrombose

Industries

Novartis
2 collaboration(s)
Dernière en 2016
Janssen
1 collaboration(s)
Dernière en 2016
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
American journal of hematology   25 février 2024
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.
Leukemia   27 décembre 2023
Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores.
American journal of hematology   05 avril 2023
Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim
Annual Meeting Abstracts 2022   15 novembre 2022
Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis.
Haematologica   01 novembre 2022
JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.
Blood cancer journal   08 avril 2022
04. Hémostase : coagulation et anticoagulants
Hématologie Congress 2022   30 mars 2022
Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis.
Annals of hematology   05 octobre 2021
Efficacy and tolerability of Janus kinase inhibitors in myelofibrosis: a systematic review and network meta-analysis.
Blood cancer journal   27 juillet 2021
Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations.
European journal of haematology   18 juillet 2021